Volume range 1-5 ml. Designed for use with large laboratory vessels.
300 L, Bulk Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...easy way to order tips. Each box contains 1000 tip...ains 200 tips (4 bags of 50 tips). Also available ...s per pack. Bulk Packs are sealed with a tamper-pr...ess to Gilsons Diamond Tips. Bulk Packs are closed...
Medicine Products:(Date:11/21/2008)..., Nov. 21 Album Creative Studios, ...s a new program offering big brand marketing for s...ge, expensive ad agency process and services, and ...s-on approach," says Matt Parker, Creative Directo...perience and proven brand-building techniques to b...
(Date:11/21/2008)... -- A Florida State University College of Medicine... an important new layer of regulation in the cell ...rstanding of the way cancer begins. , Wang, an a...ollege of Medicine, said the findings will lead to...lead to the design of new drugs that kill cancer c...
(Date:11/21/2008)...1 The Providence Service...at Craig A. Norris, the Company,s,Chief Operating...d of,Directors. Mr. Norris, appointment fills th...teven I. Geringer and returns the board to six mem... of the Board. , Mr. Norris, age 41, has be...
(Date:11/21/2008)... lead to a novel technique to combat cancer, study... News) -- Belgian researchers have discovered that...r for food, and this might lead to new treatments ...and proliferate, all cells in the body need to pro...e], a process that requires oxygen. Compared with ...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2...r-old woman in British Columbia died a lonely deat...lbo, one of her sons, is hopeful that his mom’s de... care to the senior citizens. The hospital separa...ho was also being treated at the same hospital, Ko...
... in London are all set to make a go to build a sec...nada after losing a bid to build it in their own c...y be accommodated, according to David Sloman, pote...London. Shriners in Montreal are a bit apprehensiv...
...potato' burning bright in the hands of you could p...es.According to a long-term study of nearly 85 000...s’ //found that those with the highest potato inta... developing type 2 diabetes. Obese women, who are...
...udy appearing in online edition of Gut, a journal ...elly fat may raise the risk of gallstones in older...ominal circumference and waist-to- hip ratio were ...d risk of gallstones and gall bladder removal or c...
Other Medicine News:(Date:11/19/2008)...gers $5 Million Payment from Roche- , , MON...ory Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... for its Phase 2 trial of R3487/MEM 3454, its lead...impairment associated with schizophrenia (CIAS). ...se 2 trial, triggering a $5.0 million payment from...
(Date:11/18/2008)...OWNE, Va., Nov. 18 Fort...hered at a November national forum to consider cut...blic health and national economy from outbreaks of...unced today. , , Among those innovations: ,...y American kitchen table that detects highly conta...
(Date:11/13/2008)...PS Study Suggests Nutritional Supplements Prior to...swire-USNewswire/ -- Identifying,malnutrition befo... body,contouring will significantly decrease surgi...ve scar quality and boost patient energy levels,a...ic and Reconstructive,Surgery(R), the official med...
(Date:11/12/2008)...LEVELAND, Ohio and LOD, Israel, November 12 /PRNew...Medical Center, NY indicated that,patient-specific...lator,(ANGIO Mentor(TM), Simbionix US) with high f...the simulation improved the operative flow,increa...e, decreased,overall operative and fluoroscopy tim...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Golf Spectators Should Prepare for Yellow on the Greens 14873 1Golf Spectators Should Prepare for Yellow on the Greens 14873 2MedApps Wins Nokia 2008 Mobile Rules 21 Business Plan Competition Award 14870 1MedApps Wins Nokia 2008 Mobile Rules 21 Business Plan Competition Award 14870 2MedApps Wins Nokia 2008 Mobile Rules 21 Business Plan Competition Award 14870 3Mantis shrimp vision reveals new way that animals can see 2576 1Mantis shrimp vision reveals new way that animals can see 2576 2Mantis shrimp vision reveals new way that animals can see 2576 3QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 1QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 2QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 3QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 4QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 5QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 6QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 7QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 8QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 9QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 10QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 11QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 12QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 13QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 14QED International Associates Announces Quarterly Rebalancing of HealthShares 28TM 29 Indexes 28As Revised 29 4127 15...nn.--(BUSINESS WIRE)--May 23, 2007 - Neurogen,Corp...rom previous,Phase 1 and Phase 2a clinical studies...reatment of insomnia, were presented today,at the ...ing in San,Diego. Two Phase 2b clinical studies wi...ly being conducted by the Company.,Data presented ...
....J., and BRISTOL, Tenn., May 22, 2007,/PRNewswire-...Pharmaceuticals, Inc. reported today that data fro...rial program evaluating,bremelanotide in men with ... at the American Urological Association (AUA) Annu...itive data presented,showed that bremelanotide imp...
Other Medicine Technology:Neurogen Proprietary Insomnia Compound Data Presented at American,Psychiatric Association Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at American,Psychiatric Association Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at American,Psychiatric Association Annual Meeting 4Neurogen Proprietary Insomnia Compound Data Presented at American,Psychiatric Association Annual Meeting 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 2Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 3Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 4Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 5Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 6Palatin Technologies and King Pharmaceuticals Report Data Showing,Improvements in Sexual Relationship and Self-Esteem in Patients,with Erectile Dysfunction Treated with Bremelanotide 7